efficaci
gaseou
disinfect
critic
prevent
treatment
microbi
contamin
biotechnolog
facil
evalu
gaseou
disinfect
efficaci
downscal
laboratori
model
establish
use
current
avail
carrier
test
custommad
dri
fog
box
mixtur
peroxyacet
acid
hydrogen
peroxid
paahp
investig
exampl
concentr
mlm
h
inactiv
panel
lipidenvelop
nonlipidenvelop
virus
influenza
virus
sensit
paahp
treatment
minut
viru
mice
resist
bovin
viral
diarrhea
viru
reoviru
iii
show
intermedi
stabil
similar
inactiv
kinet
use
dri
fog
box
circumv
dedic
entir
lab
investig
render
gener
data
costeffect
allow
product
highli
reproduc
kinet
data
gaseou
disinfect
procedur
commonli
use
inactiv
microb
biotechnolog
manufactur
facil
laboratori
disinfect
effect
relev
microbi
agent
howev
inform
suppli
disinfect
manufactur
necessarili
cover
target
microb
lack
inform
relev
target
prompt
varieti
past
investig
disinfect
effect
typic
perform
directli
laboratori
environ
result
data
rather
limit
experiment
setup
allow
obtain
sequenti
sampl
differ
time
inactiv
run
kinet
sampl
assess
viru
inactiv
request
regulatori
guidanc
addit
complet
laboratori
shutdown
requir
costli
time
consum
constraint
circumv
perform
smallscal
evalu
use
biosafeti
class
iii
cabinet
connect
vapor
gener
biosafeti
class
iii
cabinet
howev
rare
avail
altern
practic
approach
establish
robust
simpl
costeffect
downscal
investig
procedur
simul
practic
condit
around
biotechnolog
applic
ie
manufactur
facil
well
laboratori
unit
allow
kinet
investig
gaseou
disinfect
procedur
use
custom
made
dri
fog
box
current
avail
carrier
test
viru
inactiv
capac
minncar
dri
fog
decontamin
system
use
mixtur
peroxyacet
acid
hydrogen
peroxid
paahp
investig
panel
virus
includ
lipidenvelop
virus
bovin
viral
diarrhea
viru
bvdv
influenza
b
virus
well
nonlipidenvelop
respiratori
enter
orphan
viru
type
iii
reo
iii
parvoviru
minut
viru
mice
mvm
infecti
viru
titer
determin
median
tissu
cultur
infecti
dose
assay
tcid
use
eightfold
replic
serial
halflog
sampl
dilut
viruscontain
sampl
titrat
cell
line
indic
cell
incub
c
cytopath
effect
evalu
visual
inspect
invert
microscop
nikon
eclips
tcid
titer
calcul
accord
poisson
distribut
express
log
tcid
ml
viru
reduct
factor
calcul
accord
eu
committe
proprietari
medicin
product
guidanc
least
two
independ
run
inhous
custom
made
dri
fog
box
consist
acryl
glass
box
fig
design
fit
common
laminar
flow
bench
class
ii
outer
dimens
box
later
manipul
open
three
rubbers
slot
bottom
front
side
includ
three
movabl
carrier
slide
twelv
sampl
holder
two
ventil
insid
box
ensur
homogen
distribut
disinfect
confirm
measur
rel
humid
rh
vari
differ
record
temperatur
rel
humid
record
four
ts
x
logger
unit
tracksens
pro
sky
access
point
modul
data
monitor
done
valid
softwar
valsuitepro
ellab
hillero
denmark
run
ml
viru
stock
suspens
describ
astm
standard
dri
two
h
center
point
epolish
stainless
steel
carrier
cm
aisi
type
baumgartn
co
gmbh
vienna
austria
transfer
dri
fog
box
minntech
dri
fog
unit
cantel
medic
corpmar
cor
littl
fall
nj
connect
diffus
head
via
magnet
valv
regul
aqueou
minncar
cold
steril
contain
peroxyacet
acid
paa
hydrogen
peroxid
hp
releas
box
paahp
solut
appli
four
differ
run
design
ieiv
increas
concentr
rang
mlm
run
design
mlm
run
design
iv
paahp
solut
concentr
calcul
accord
excel
spreadsheet
minncar
dri
fog
calcul
provid
minncar
first
min
run
design
ii
ml
paahp
solutionm
refog
perform
soon
rh
decreas
kinet
sampl
drawn
min
min
min
min
pull
sampl
holder
dri
ts
x
logger
eunit
dri
fog
gener
unit
manomet
diffus
head
dri
fog
unit
slipcas
sampl
holder
tabl
viru
inactiv
paahp
treatment
mean
viru
titer
ci
valu
given
log
tcid
ml
viru
control
recov
viru
titer
obtain
dri
phase
titer
sampl
stage
use
calcul
reduct
factor
b
influenza
virus
flu
b
viru
titer
calcul
success
neg
sampl
given
viral
infect
detect
success
kinet
sampl
final
sampl
volum
success
neg
sampl
taken
account
calcul
assay
detect
limit
lipidenvelop
virus
b
nonenvelop
virus
n
number
sampl
seri
na
applic
fog
box
vortex
metal
carrier
rpm
plastic
tube
contain
steril
glass
bead
mm
ml
appropri
cell
cultur
medium
similar
doerrbeck
et
al
nonlipid
envelop
virus
addit
sampl
drawn
min
min
supernat
immedi
use
tcid
titrat
initi
recoveri
dri
viru
infect
stainless
steel
carrier
investig
relat
input
viru
titer
appli
stainless
steel
carrier
recoveri
titer
reduc
log
tcid
ml
mean
n
bvdv
respect
reo
iii
n
mvm
n
remain
unchang
latter
result
indic
viru
infect
could
complet
recov
dri
stainless
steel
impact
mvm
reo
iii
infect
dri
fog
disinfect
use
paahp
solut
mlm
run
design
reveal
rapid
inactiv
influenza
virus
investig
flu
b
titer
detect
limit
min
treatment
sampl
seri
viru
inactiv
run
perform
tabl
contrast
bvdv
inactiv
disinfect
concentr
min
treatment
mere
log
tabl
fig
doubl
amount
paahp
solut
mlm
run
design
ii
result
inactiv
bvdv
log
total
inactiv
time
min
tabl
fig
similar
inactiv
kinet
found
reo
iii
log
viru
infect
inactiv
min
treatment
run
design
log
higher
disinfect
concentr
run
design
ii
tabl
fig
complet
inactiv
period
min
reo
iii
inactiv
log
run
design
log
run
design
ii
respect
tabl
fig
mvm
inactiv
log
low
paa
hp
solut
amount
run
design
min
tabl
fig
applic
paahp
solut
amount
mlm
includ
repeat
refog
maintain
nearli
constant
paa
hp
concentr
first
min
treatment
show
inactiv
log
mvm
fig
inactiv
detect
limit
could
achiev
mvm
min
treatment
mlm
paahp
solut
run
design
iv
tabl
fig
assess
accuraci
experiment
setup
variabl
result
evalu
compar
distinct
reduct
factor
obtain
viru
run
design
respect
variabl
reduct
factor
rang
log
reo
iii
run
design
ii
n
log
bvdv
run
design
n
mean
overal
reduct
factor
variabl
log
n
panel
virus
studi
chosen
repres
one
hand
target
virus
ie
three
influenza
strain
due
import
humananim
pathogen
gener
hand
model
virus
ie
bvdv
reo
iii
mvm
recommend
regulatori
guidelin
viru
clearanc
studi
sinc
reo
iii
mvm
alreadi
report
contamin
biotechnolog
process
relev
target
virus
gaseou
disinfect
differ
virus
dri
stainless
steel
use
paahp
show
highli
variabl
viru
inactiv
effici
influenza
virus
sensit
mvm
least
sensit
paahp
treatment
howev
lipidenvelop
bvdv
nonenvelop
reo
iii
compar
stabl
indic
nonenvelop
virus
might
necessarili
stabl
lipidenvelop
virus
often
assum
within
studi
paahp
solut
concentr
mlm
appli
viru
inactiv
min
cover
manufactur
recommend
use
mlm
paahp
solut
min
ie
run
design
iii
studi
data
viru
inactiv
provid
manufactur
show
effect
inactiv
polioviru
human
coronaviru
human
immunodefici
viru
use
suspens
test
howev
meaning
regard
applic
dri
fog
underlin
requir
conduct
relev
disinfect
efficaci
studi
found
alreadi
lower
paahp
concentr
run
design
suffici
inactiv
influenza
virus
mvm
could
partial
inactiv
run
design
iii
inactiv
detect
limit
ie
log
requir
min
treatment
elev
paahp
solut
concentr
run
design
iv
mlm
mvm
target
viru
ie
contamin
biotechnolog
facil
specif
viru
extend
disinfect
period
would
consid
earlier
investig
shown
inactiv
reo
iii
mvm
detect
limit
min
exposur
time
appli
mlm
paahp
solut
roughli
higher
concentr
data
gener
compar
find
howev
clear
comparison
possibl
draw
kinet
sampl
feasibl
within
limit
whole
laboratori
fog
setup
chosen
consequ
safeti
margin
inactiv
approach
could
assess
